Atlas Trials

A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021

Clinical trial NCT01560403 · COMPLETED

Trial details

NCT number
NCT01560403
Sponsor
Shire
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Short Bowel Syndrome
Start date
2012-05-21
Primary completion
2013-07-23
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.